| 
Nitric
Oxide Delivery from Wound Dressings
Nitric oxide has been shown to promote angiogenesis through stimulation of VEGF
and increase fibroblast collagen synthesis. The NO-producing hydrogels
provide both a moist wound dressing and localized production of
NO to improve healing.
:: Rationale
NO
has multiple physiological roles at the cellular and tissue level.
In wounded skin, NO has been reported as increasing granulation
tissue formation and collagen synthesis. Delivery of NO from hydrogel
wound dressings can benefit wound healing by providing NO at therapeutic
levels and by creating a moist environment for optimal healing.
:: Technology Description
Fast
crosslinking PVA based prepolymers (or the formed hydrogel), modified
with amine groups, are exposed to NO gas. The amine groups act as
nucleophiles and a complex forms between the prepolymers or hydrogel
and NO. On exposure to physiological conditions, the NO is released
by hydrolysis and is able to act at the site of delivery. PVA-NO
hydrogels can be sterilized by filtration and shelf-life can be
extended by storage at low temperature or low pH. The NO loading
can be varied by altering the % amine substitution and the exposure
time to NO gas.
:: Results to Date
Production
of collagen by human dermal fibroblasts (HDF) increased in vitro
(Figure A) while a relatively constant overall level of extracellular
matrix (ECM) was maintained (Figure B).
 |
 |
| A.
Total Collagen Production |
B.
Total ECM Production |
Preliminary
studies have been conducted to examine the effect of PVA-NO hydrogels
on wound healing in a genetically diabetic mouse model. Wound healing
in this model is impaired, usually by a two to threefold decrease
in wound closure rate and wound strength. This is similar to the
impaired wound healing experienced by humans with diabetes and is
thought to be due in part to reduction of NO production. Wound closure
rate was not significantly different between control and PVA-NO
hydrogels in the diabetic mouse model; however granulation tissue
thickness and scar tissue thickness were substantially higher in
the PVA-NO groups (see Figures C and D below) suggesting improved
healing and wound strength.
 |
 |
| C:
Granulation Tissue Formation |
D.
Scar Tissue Formation |
::
Patent Position
Issued
patents for the fast crosslinking PVA hydrogel system. Patents pending
for use of the PVA hydrogel system for preformed and in situ formed
wound dressings and for nitric oxide producing hydrogel materials.
Please
contact us if you have any questions.
We'd be happy to provide you with more information.
|